Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities.

Autor: Cobani, Era, Al Hallak, Mohammed Najeeb, Shields, Anthony F., Maier, Jordan, Kelly, Thomas E., Naidoo, Niren, Tobon, Miguel, Kim, Steve, Beal, Eliza W.

Publikováno v: Journal of Gastrointestinal Cancer; Jun2024, Vol. 55 Issue 2, p519-533, 15p

Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management.

Autor: Elderkin, Jessica, Al Hallak, Najeeb, Azmi, Asfar S., Aoun, Hussein, Critchfield, Jeffrey, Tobon, Miguel, Beal, Eliza W.

Publikováno v: Cancers; Nov2023, Vol. 15 Issue 21, p5118, 21p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.

Autor: Khan HY; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Nagasaka M; University of California Irvine School of Medicine, Orange, California; Chao Family Comprehensive Cancer Center, Orange, California.; Division of Neurology, Department of Internal Medicine, St. Marianna University, Kawasaki, Japan., Aboukameel A; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Alkhalili O; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Uddin MH; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Bannoura SF; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Mzannar Y; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Azar I; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Beal EW; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Tobon ME; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Kim SH; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Beydoun R; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Baloglu E; Karyopharm Therapeutics, Newton, Massachusetts., Senapedis W; Karyopharm Therapeutics, Newton, Massachusetts., El-Rayes BF; University of Alabama, Birmingham, Alabama., Philip PA; Henry Ford Health, Detroit, Michigan.; Department of Pharmacology, Wayne State University, Detroit, Michigan., Mohammad RM; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Shields AF; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Al Hallak MN; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan., Azmi AS; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2023 Dec 01; Vol. 22 (12), pp. 1422-1433.